期刊文献+

肝脏获得性表达apobec-1基因治疗肾性高脂血症研究概况 被引量:1

肝脏获得性表达apobec-1基因治疗肾性高脂血症研究概况
原文传递
导出
摘要 高脂血症(hyperlipidemia,HLP)是各种原发性和继发性肾脏疾病典型的临床特征之一,以血浆总胆固醇(total cholesterol,TC)、甘油三酯(triglyceride,TG)、低密度脂蛋白胆固醇(low—density lipoprotein cholesterol,LDL—C)和脂蛋白a[lipoprotein(a),Lp(a)]浓度显著升高为主要表现。
出处 《中国实用儿科杂志》 CSCD 北大核心 2011年第6期474-476,共3页 Chinese Journal of Practical Pediatrics
基金 国家自然科学基金资助项目(81000306) 安徽医科大学校科研基金资助项目(2010xkj055) 安徽医科大学第一附属医院博士启动基金资助项目(2009kj02)
关键词 载脂蛋白B编辑催化多肽 肾脏疾病 高脂血症 腺病毒 转染 apoB editing catalytic polypeptide kidney disease hyperlipidemia adenovirus lransfection
  • 相关文献

参考文献25

  • 1Hu P, Lu L, Hu B, et al. Characteristics of lipid metabolism un- der different urinary protein excretion in children with primary nephrotie syndrome [ J ]. Stand J Clin Lab Invest, 2009, 69 (6) : 680-686.
  • 2Zbou Y, Zhang X, Chen L, et al. Expression profiling of hepatic genes associated with lipid metabolism in nephrotic rats [J]. Am J Physiol Renal Physiol, 2008,295 ( 3 ) : F662-671.
  • 3Ritz E, Wanner C. Lipid abnormalities and cardiovascular risk in renal disease [J]. J Am Soc Nephrol, 2008, 19 (6) : 1065 - 1070.
  • 4胡鹏,经承学,覃远汉,裴娟,李铭芳.原发性肾病综合征患儿血脂代谢紊乱的肾毒性作用[J].中国实用儿科杂志,2007,22(2):121-123. 被引量:10
  • 5Walker DB, Walker TJ, Jacobson TA. Chronic kidney disease and statins: improving cardiovascular outcomes [J]. Curr Ath- erosclerosis Rep, 2009,11 ( 4 ) : 301-308.
  • 6Anonymous. Comparative efficacy and safety of pravastatin and cholestyramine alone and combined in patients with hypereho- lesterolemia. Pravastatin Multicenter Study Group Ⅱ [J]. Arch Intern Med, 1993,153( 11 ) : 1321-1329.
  • 7Dirisamer A, Stadler A, Bucek RA, et al. ApoB-100 and ApoB/ ApoA-1 ratio in children and adolescenls from families with very early myocardial infarction [J]. Acta Pacdiatr, 2006, 95 (7): 810-813.
  • 8Lo CM, Nordskog BK, Nauli AM, et al. Why does the gul choose apolipoprotein B48 hut not B100 for chylomicron formation? [J]. Am J Physiol Gastrointest Liver Physiol, 2008, 294 ( 1 ) : G344-352.
  • 9Blanc V, Davidson NO. C-to-U RNA editing: mechanisms leading to genetic diversily [J]. J Biol Chem, 2003, 278 (3) : 1395-1398.
  • 10胡鹏,鹿玲,胡波,覃远汉.人类载脂蛋白B编辑催化多肽-1的生物信息学分析[J].现代预防医学,2009,36(20):3933-3936. 被引量:1

二级参考文献19

  • 1李卫中,洪敏,李琦涵.APOBEC家族:介导天然抗病毒免疫的新型宿主细胞因子[J].病毒学报,2006,22(1):74-78. 被引量:5
  • 2庄华梅,何德.核磁共振技术及其在生命科学中的应用[J].生物磁学,2005,5(4):58-61. 被引量:11
  • 3Navaramam N, Fujino T, Bayliss J, et al. Escherichia coli cytidine deaminase provides a molecular model for ApoB RNA editing and a mechanism for RNA substrate recognition [J], J Mol Biol, 1998, 275 (4): 695-714.
  • 4Xie K, Sowden MP, Dance GS, et al. The structure of a yeast RNA-editing deaminase provides insight into the fold and function of activation-induced deaminase and APOBEC-1 [J]. Proc Natl Acad Sci U S A, 2004, 101 (21): 8114-8119.
  • 5Harris RS, Petersen-Mahrt SK, Neuberger MS. RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators [J]. Mol Cell, 2002, 10 (5): 1247-1253.
  • 6Chester A, Weirtreb V, Carter CW Jr, et al. Optimization of apolipoprotein B mRNA editing by APOBEC1 apoenzyme and the role of its auxiliary factor, ACF[J]. RNA, 2004, 10 (9) : 1399- 1411.
  • 7Yang Y, BaUatori N, Smith HC. Apolipoprotein B mRNA Editing and the Reduction in Synthesis and Secretion of the Atherogenie Risk Factor, Apolipoprotein B100 Can Be Effectively Targeted through TAT-Mediated Protein Transduetion [J]. Mol Pharmacol, 2002, 61 (2): 269-276.
  • 8Yamanaka S, Balestra ME, Ferrell LD, et al. Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals[J]. Proc Natl Acad Sci U S A, 1995, 92 (18) : 8483-8487.
  • 9Bukrinskaia AG, Vorkunova GK, Burshtein ME. Assembly and maturation of HIV-1-targets for new anti-HIV compounds [J]. Mol Gen Mikrobiol Virusol, 2005 (1): 18-23.
  • 10Bagga A, Mantan M. Nephrotic syndrome in children [ J ]. Indian J Med Res, 2005,122( 1 ) :13-28.

共引文献9

同被引文献21

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部